Bioelectric Medicine Market Growth and Restrain Factors Analysis Report

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Bioelectric Medicine Market Size, Share & Trends Analysis Report By Product (Pacemaker, ICD, Cochlear Implant, Deep Brain, Spinal Cord, Vagus, Sacral Nerve Stimulators), Application (Ischemia, Epilepsy), Type (Implantable, Noninvasive), End User (Hospitals, Clinics, & ASCs)- Market Outlook And Industry Analysis 2031"

The Global Bioelectric Medicine Market is estimated to reach over USD 43.03 billion by 2031, exhibiting a CAGR of 7.72 % during the forecast period.

Request for free Sample Pages:
https://www.insightaceanalytic.com/request-sample/1379

Electroceuticals, also referred to as bioelectric medicine, encompass a range of medical devices that utilize electrical signals and impulses from the nervous system. This field combines molecular medicine, neuroscience, and bioengineering to develop devices that stimulate nerves and modify biological processes for the treatment of various diseases. Key examples of electroceuticals include implantable defibrillators, cardiac pacemakers, cochlear implants, retinal implants, pain relief devices, and spinal cord stimulators. The growth of this sector is primarily driven by the increasing global incidence of cardiovascular and neurological conditions, alongside an aging population.

Bioelectric medicine leverages technologies such as transcutaneous electric nerve stimulators, vagus nerve stimulators, and deep brain stimulators to address these health challenges. The rising prevalence of arrhythmias, which are commonly treated with cardiac pacemakers and implantable cardioverter-defibrillators, is further fueling market growth.

List of Prominent Players in the Bioelectric Medicine Market:
• Abbott Laboratories, Inc. (US)
• Axonics Modulation Technologies, Inc. (US)
• BioControl Medical (Israel)
• Bioinduction Ltd. (UK)
• BIOTRONIK (Germany)
• Biotronik SE & Co KG
• Boston Scientific Corporation
• Cefaly (Belgium)
• Cochlear Ltd.
• electroCore, Inc.
• GiMer Medical (Taiwan)
• LivaNova PLC (UK)
• MED-EL (Austria)
• Medico S.p.A. (Italy)
• Medtronic
• MicroPort Scientific Corporation (China)
• Neuro ace, Inc. (US)
• Neuronetics, Inc. (US)
• Nevro Corp.
• Nurotron Biotechnology Co. Ltd. (US)
• Second Sight Medical Products, Inc. (US)
• Sonova Group (Switzerland)
• Soterix Medical Inc. (US)
• Stimwave LLC
• TVNS Technologies GmbH (Germany)

Market Dynamics:
Drivers-
A primary factor driving the growth of the electroceuticals market is the increasing prevalence of chronic and severe illnesses worldwide. Electroceuticals have gained significant consumer acceptance for treating a wide range of cardiac and neurological disorders, such as dystonia, essential tremor, obsessive-compulsive disorder (OCD), epilepsy, Alzheimer's disease, Parkinson's disease, and arrhythmia. These developments are central to market expansion. Additionally, the growing aging population, which is more susceptible to neurological conditions, is expected to further fuel market growth during the forecast period.

Curious about this latest version of the report? @
https://www.insightaceanalytic.com/enquiry-before-buying/1379

Challenges:
A major challenge faced by the market is the high cost of electroceutical devices, which is particularly problematic in developing nations. For example, the cost of a cochlear implant is approximately Rs. 430,000, while pacemaker surgery ranges from Rs. 275,000 to Rs. 300,000, whereas the average national income is around Rs. 135,050. As a result, these high costs make it difficult for many individuals to afford electroceutical devices, thereby limiting demand. Additionally, overly stringent government regulations may hinder the development and production of medical devices such as implantable cardioverter defibrillators, cardiac pacemakers, and neuromodulation devices.

Regional Trends:
The North American bioelectric medicine market is expected to hold a significant share in terms of revenue and is projected to grow at a high compound annual growth rate (CAGR) in the near future. This growth is attributed to substantial investments in research and development, increased adoption of advanced technologies, the presence of major companies, and a robust healthcare infrastructure. Moreover, rising healthcare expenditures in the region are driving the sector, while recent FDA approvals of several bioelectrical devices are accelerating the adoption of electroceuticals.

Recent Developments:
• In July 2021, graphene-based bioelectronic vagus nerve therapies for severe chronic disorders are being developed by Innervia Bioelectronics in collaboration with Merck KGaA, Darmstadt, Germany (Merck). To develop treatments for illnesses with unmet medical needs that fall within Merck's areas of expertise, the two businesses will combine their expertise.
• In November 2020, Medtronic announced that their friendly tender offer for Medicrea International, situated in France, had been accepted. As a result, Medtronic presently holds most of the voting and share capital of Medicrea. Medicrea International is a leader in using artificial intelligence (AI), predictive modeling, and patient-specific implants to change spinal surgery.

Get Specific Chapter/Information From The Report:
https://www.insightaceanalytic.com/customisation/1379

Segmentation of Bioelectric Medicine Market-
By Product
• Cardiac Pacemakers & Implantable Cardioverter
Defibrillators
• Spinal Cord Stimulators
o Chronic Pain
o Failed Back Surgery Syndrome
o Cerebral Ischemia
• Cochlear Implants
• Deep Brain Stimulators
o Parkinson's Disease
o Tremors
o Depression
o Other DBS Applications
• Sacral Nerve Stimulators & Gastric Electrical
Stimulators
o Urinary Incontinence
o Fecal Incontinence
o Gastroparesis
• Transcutaneous Electrical Nerve Stimulators
o Treatment-resistant Depression
o Other TENS Applications
• Vagus Nerve Stimulators
o Epilepsy
o Other VNS Applications
• Other Electrical Stimulators
By Type
• Implantable Electroceutical Devices
• Noninvasive Electroceutical Devices
By End User
• Hospitals, Clinics, & ASCs
• Other End Users
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

Get more information: @
https://www.insightaceanalytic.com/report/global-bioelectric-medicine-market/1379

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.https://www.insightaceanalytic.com/images_data/148861653.JPG

Contact us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/Insightace

This release was published on openPR.